DEXCOM INC (1DXCM.MI) Stock Overview
Europe - BIT:1DXCM - US2521311074 - Common Stock
1DXCM.MI Key Statistics, Chart & Performance
The current stock price of 1DXCM.MI is 55.51 EUR.
1DXCM.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 27.42 | 200.47B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 56.1 | 138.57B | ||
| 1BSX.MI | BOSTON SCIENTIFIC CORP | 34.3 | 122.99B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 34.21 | 122.69B | ||
| 2M6.DE | MEDTRONIC PLC | 17.72 | 107.75B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 20.36 | 54.66B | ||
| 1SHL.MI | SIEMENS HEALTHINEERS AG | 19.19 | 51.52B | ||
| BOX.DE | BECTON DICKINSON AND CO | 13.36 | 46.81B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 30 | 38.75B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.71 | 23.17B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.69 | 23.15B | ||
| DC4.DE | DEXCOM INC | 39.14 | 22.41B |
Related stock screener links
About 1DXCM.MI
Company Profile
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. The company is headquartered in San Diego, California and currently employs 10,300 full-time employees. The company went IPO on 2005-04-14. The firm is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The firm enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.
Company Info
DEXCOM INC
6340 Sequence Dr
San Diego CALIFORNIA US
Employees: 10300
Phone: 18582000200
DEXCOM INC / 1DXCM.MI FAQ
What is the stock price of DEXCOM INC today?
The current stock price of 1DXCM.MI is 55.51 EUR. The price decreased by -5.5% in the last trading session.
What is the ticker symbol for DEXCOM INC stock?
The exchange symbol of DEXCOM INC is 1DXCM and it is listed on the Euronext Milan exchange.
On which exchange is 1DXCM.MI stock listed?
1DXCM.MI stock is listed on the Euronext Milan exchange.
What is DEXCOM INC worth?
DEXCOM INC (1DXCM.MI) has a market capitalization of 21.77B EUR. This makes 1DXCM.MI a Large Cap stock.
How many employees does DEXCOM INC have?
DEXCOM INC (1DXCM.MI) currently has 10300 employees.
Is DEXCOM INC (1DXCM.MI) expected to grow?
The Revenue of DEXCOM INC (1DXCM.MI) is expected to grow by 14.99% in the next year. Check the estimates tab for more information on the 1DXCM.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DEXCOM INC (1DXCM.MI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of 1DXCM.MI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of 1DXCM.MI, evaluating the profitability, health, valuation and growth aspects
- DEXCOM INC (1DXCM.MI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DEXCOM INC (1DXCM.MI) Sales and EPS estimates to see what analysts future expectations are.
- DEXCOM INC (1DXCM.MI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DEXCOM INC (1DXCM.MI) Insider and Institutional Ownership to learn about the owners and their transactions.
- DEXCOM INC (1DXCM.MI) Stock Chart to make your own analysis
- DEXCOM INC (1DXCM.MI) Latest news and press-releases to stay up to date.
Does DEXCOM INC (1DXCM.MI) stock pay dividends?
1DXCM.MI does not pay a dividend.
When does DEXCOM INC (1DXCM.MI) report earnings?
DEXCOM INC (1DXCM.MI) will report earnings on 2025-10-30, after the market close.
What is the Price/Earnings (PE) ratio of DEXCOM INC (1DXCM.MI)?
The PE ratio for DEXCOM INC (1DXCM.MI) is 38.02. This is based on the reported non-GAAP earnings per share of 1.46 and the current share price of 55.51 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1DXCM.MI.
1DXCM.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 1DXCM.MI.
1DXCM.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 1DXCM.MI. 1DXCM.MI has an excellent profitability rating, but there are some minor concerns on its financial health.
1DXCM.MI Financial Highlights
Over the last trailing twelve months 1DXCM.MI reported a non-GAAP Earnings per Share(EPS) of 1.46. The EPS decreased by -2.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.29% | ||
| ROA | 7.8% | ||
| ROE | 22.21% | ||
| Debt/Equity | 0.5 |
1DXCM.MI Forecast & Estimates
For the next year, analysts expect an EPS growth of 26.84% and a revenue growth 14.99% for 1DXCM.MI